Delivery Order SPE2DB20D1100-SPE2DB24FA7R6
- Not listed
- This federal contract award, valued at $12,107.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. The contract provides for the delivery of XYLOCAINE 1%-EPI 1:100,000 50ML, a pharmaceutical...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,009.20 fixed-price delivery order is for XYLOCAINE 2%-EPI 1:200,000 20ML, a specialty medication. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a delivery order valued at $2,446.05 for the supply of XYLOCAINE 2%-EPI 1:200,000 20ML pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of XYLOCAINE-MPF 1% VIAL 30ML, a pharmaceutical product. The award, valued at $1,301.92, is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of XYLOCAINE-MPF 1% VIAL 5ML pharmaceutical products to the Defense Logistics Agency (DLA). The firm fixed price delivery order contract has a potential value of $1,042.89 and a period of performance through February 7, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this award, which is not associated with any set-aside designation. The company has a...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the Corporate Office division of Amerisourcebergen Drug Corp. The $1,392.24 Firm Fixed Price Delivery Order is for the supply of XYLOCAINE-MPF 1% VIAL 30ML medical products. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceuticals and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.11 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a pharmaceutical product, with a period of performance ending on October 31, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, which is a Delivery Order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), is for the supply of XYLOCAINE 2%-EPI 1:200,000 20ML, a local anesthetic medication. The award has a ceiling value of $1,811.28 and an ultimate completion date of July 19, 2024. The contract is a Firm Fixed Price arrangement. There is no...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $1,179.40, is for the delivery of pharmaceutical products, specifically XYLOCAINE-MPF 1%-EPI 1:200,000 30ML, to support various government agencies and healthcare programs. The contract is a firm fixed-price Delivery Order, with a period of performance running through September 2024. Amerisourcebergen, a major supplier of...
- This federal contract award, identified as SPE2DX15D7057|SPE2DX24FLCEW, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract, which is not set aside, is for the delivery of XYLOCAINE-MPF 1% VIAL 30ML, a pharmaceutical product. The award has a ceiling value of $1,487.42 and a completion date of August 2, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA7R6Delivery Order
This is a delivery order award to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,893.73 firm fixed price contract is for the delivery of XYLOCAINE 1%-EPI 1:100,000 50ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 held by AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract. AmerisourceBergen Drug Corp is a for-profit organization that specializes in pharmaceutical sourcing and distribution services, and has received numerous federal contract awards from DLA to supply medications, medical materials, and related services in support of military treatment programs and facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 3/15/24 |